In its September issue, Pharmaceutical Commerce details the previous and expected contributions of biologic products to its forecast of cold-chain market growth predicting sales of cold-chain drugs and biologics will outpace overall industry growth through 2022. It is reported that “as of 2018, global...
Wednesday, September 12, 2018 | Read More
In a recent news release the FDA described research it has conducted regarding detection of protein carbonylation, an oxidative reaction that may occur in therapeutic protein drug products during manufacture, storage, use, and transport potentially causing structural alterations and threatening stability,...
Tuesday, September 11, 2018 | Read More
Sentry BioPharma Services is pleased to announce delegates from Sentry’s Business Development team will be in New York City attending the Drug, Chemical & Associated Technologies Association (DCAT) Week March 19th -22nd. The four-day conference brings together key sourcing, procurement and business...
Monday, March 19, 2018 | Read More
Temperature-sensitive product guardianship involves an exacting approach to handling and transporting precious biopharma materials and products. Instead of meeting minimum safety and security requirements for temperature-sensitive materials, Sentry provides a highly specialized level of security and assurance throughout every stage of storage and handling. Guardianship results in the successful handling, transport and storage of temperature-sensitive products and materials.
Sentry's processes extend beyond pharmaceutical cold chain management to create a value chain, affecting everything from raw materials storage to resolving import/export issues. Sentry seamlessly couples internal and external expertise to develop and deliver unprecedented value in storage, packaging, material management, distribution and process management of temperature-sensitive materials and legend drugs.
You should turn to Sentry when temperature sensitivity is a vital factor in your biopharma products or components. Sentry is ideal for any pharmaceutical or biotech interest that manages highly sensitive materials, components and products for purposes of clinical trials, product development, manufacturing or commercial distribution. Unplanned temperature excursions at any point in the legend lifecycle can cause devastating setbacks-losing valuable time, wasting resources and costing dollars. If you need certainty that your investment in materials or research won't be affected by temperature deviation, you need Sentry.
If you need contract warehousing and/or custom packaging services for consumer goods or low-cost commodities where temperature sensitivity is a low-priority issue, you may not need Sentry. Sentry exclusively serves the healthcare industry. Many other companies store, transport and package various items without the level of expertise, precision and security that Sentry provides.
Sentry provides biopharma services for the following organization types:
Sentry provides biopharma solutions for the following product types:
By providing pharmaceutical supply chain management, Sentry contributes confidence, efficiency and compliance. Sentry instills confidence in its clients by executing outsourced pharmaceutical operations with the highest level of reliability and responsiveness. With a continuous improvement culture, Sentry develops and refines client solutions that meet deadlines and budget expectations. Key business drivers are identified and targeted for process improvement when appropriate. Finally, Sentry built its service offering on a foundation of quality, with consistent audits and education that positions Sentry as a leader in compliance.
A team of life sciences and project management professionals founded Sentry BioPharma Services in 2004. The founders developed Sentry to meet the rapidly growing demand for storage and management solutions in the pharmaceutical and biotechnology sectors. Sentry was conceived specifically to protect temperature-sensitive products throughout the pharmaceutical supply chain.
Sentry BioPharma Services is located in Indianapolis, adjacent to the Indianapolis International Airport. Indianapolis International ranks as the eighth largest cargo airport in the U.S. and houses a major FedEx hub, which accommodates late drop-offs. Sentry's facility is accessible to 75% of all U.S. businesses within a one-day drive, and it occupies a Foreign Trade Zone, which can reduce duties, inventory taxes and brokerage fees.
Sentry operates a 53,000-square-foot facility, devoting 50,000 square feet to GMP warehousing and distribution. Sentry incorporated readiness for expansion and the addition of new technology into its original design. The facility maintains dedicated and restricted storage space, with a separate location for secondary packaging operations, and enhanced security for high-risk products.
Sophisticated physical and data security measures protect client materials throughout all stages of storage, handling and distribution. Sentry's robust security program encompasses market trends, industry best practices and audit feedback. For specific security-related questions, please contact Sentry BioPharma Services at 1-866-757-7400 or via email at email@example.com.
Sentry utilizes industry-leading temperature-monitoring equipment and building management systems within its GMP facility. Backup systems are capable of running all essential systems. Sentry also conducts ongoing assessments of all SOPs (standard operating procedures) and processes. For specific temperature-monitoring questions, please contact Sentry BioPharma Services at 1-866-757-7400 or via email at firstname.lastname@example.org.
There are many, including: